Medication info
Heuons Amoxicra 625 mg (Amoxicillin Trihydrate · Clavulanate Potassium)

Heuons Amoxicra 625 mg (Amoxicillin Trihydrate · Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Heuons Co., Ltd.
Appearance
This medication is an oval film-coated tablet that is white or almost white.
Packaging
40 tablets (4 tablets/PTP x 10)
Approval status
Active

MFDS item code 201707539 · Approved 2017.10.20 · Insurance code 670607800

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the beginning of a meal. ○ In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. - Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with a creatinine clearance (CrCl) of 30mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg of amoxicillin/potassium clavulanate or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)
Child dose
○ Adults and children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally every 8 hours, 3 times daily. For severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. - Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Heuons Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is used to treat various bacterial infectious diseases. It improves respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, and lung abscesses, and is effective for tonsillitis, sinusitis, and otitis media. It also helps treat urinary tract infections such as cystitis, urethritis, and pyelonephritis. It is used for pelvic infections and gonorrhea, and is effective for boils, abscesses, soft tissue infections, wound infections, osteomyelitis, and dental infections. Thus, it is widely used for various bacterial infectious diseases, improving the symptoms of infections.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the beginning of a meal. ○ In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. - Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with a creatinine clearance (CrCl) of 30mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg of amoxicillin/potassium clavulanate or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)

Child dose

○ Adults and children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally every 8 hours, 3 times daily. For severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. - Children: Reduce the dose in the same manner.

Precautions

This drug is a beta-lactam antibiotic and should not be used in patients who are hypersensitive to penicillin or cephalosporin agents or have experienced serious allergic reactions such as anaphylaxis, Stevens-Johnson syndrome, or shock in the past. Additionally, in patients with viral infections such as infectious mononucleosis or lymphocytic leukemia, there is a high risk of rash, so this medication should be avoided. Patients with liver dysfunction or a history of jaundice should also be cautious when using this medication, as symptoms may recur. Patients with liver dysfunction should be used cautiously as their liver function may worsen, and those with moderate to severe renal impairment may need to adjust dosing intervals because the blood levels of this drug may increase. Patients with allergic backgrounds or family histories, those who have difficulty taking orally, the elderly, and those in poor general condition should be particularly cautious as they may experience vitamin K deficiency symptoms. Gastrointestinal symptoms can include diarrhea, vomiting, abdominal pain, and indigestion, and in severe cases, pseudomembranous colitis or acute pancreatitis may occur, necessitating immediate discontinuation of the medication and consultation with a doctor if symptoms are severe. Liver function abnormalities may also rarely occur, particularly in elderly males over the age of 60, and symptoms may appear during or after treatment, necessitating regular liver function tests. Skin rashes, itching, and in severe cases, serious skin reactions like Stevens-Johnson syndrome or toxic epidermal necrolysis may occur, so any abnormal symptoms should result in immediate discontinuation of the medication. Hematologic abnormalities such as leukopenia, thrombocytopenia, and anemia may occur rarely, so attention should be paid to bleeding tendencies or signs of infection. Central nervous system symptoms can include anxiety, confusion, drowsiness, and seizures rarely, especially with an increased risk of seizures in patients with renal impairment. Renal function abnormalities may also rarely occur; hence, regular renal function tests are necessary, and if abnormalities are found, treatment should be ceased. This medication can impact intestinal bacterial balance and may result in fungal infections such as candidiasis, necessitating appropriate action if symptoms arise. There may be a risk of bleeding due to vitamin K deficiency, particularly with long-term use, especially in the elderly, who may exhibit bleeding tendencies. This medication may interact with other drugs, especially anticoagulants, anti-inflammatory drugs, and certain antibiotics, so caution is required when used in combination. Use should be avoided during the first three months of pregnancy, and pregnant or breastfeeding women should consider the necessity and risks carefully, as side effects like diarrhea or skin rashes may appear in infants during breastfeeding. It is recommended to use this medication only in children aged 12 and older or weighing over 40 kg, and elderly patients should be treated cautiously with adjusted dosages and intervals due to the higher risk of side effects due to physical decline. In case of overdose, gastrointestinal disturbances, drowsiness, and rashes may occur, so immediate medical attention is necessary. This medication can be removed by hemodialysis. This medication should be stored in a sealed container to prevent moisture and kept in a cool, dry place below 25 degrees Celsius. It is important to consult medical staff immediately if abnormal symptoms such as diarrhea or skin rashes occur during medication use.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, soft stools, xerostomia, acute pancreatitis, candidiasis, antibiotic-induced colitis, bloody stools, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous pemphigoid, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal burning, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, convulsions, antispasmodic, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral convulsions, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent moisture and kept in a cool, dry place below 25 degrees Celsius. This storage method will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

This medication is an oval film-coated tablet that is white or almost white.

Package unit

40 tablets (4 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.